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Abstract: It has been revealed that in alloxane
diabetes the content of the main
phospholipids
–
phosphatidylcholine,
phosphatidyletanolamine and phosphatidylphosphatidylinosite –decreases in the cells of
the vascular wall, whereas the content of the
methyl ethers of the fatty acids is not
changed, and the content of the fractions of
lipids
(monoglycerides,
diglycerides,
triglycerides, cholesterol, free fatty acids, and
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Introduction
Numerous publications concerning functional and
morphological changes in the vessel walls taking place
during various diseases reveal an idea of the qualitative
homogeneity of these changes in the arteries and veins.
Therefore, in spontaneously hypertensive rats the
shortening of larger and narrower vessels, as well as the
narrowing of the capillary-forming vessels in both parts
of the channel of a skeletal muscle were recorded (1,2).
Impregnation of the vessel walls by blood plasma, its
thickening and subsequent fibrosis are recorded both in
the arteries (3-5) and in the veins (6). According to vital
and posthumous observations of diabetic patients (7),
vascular abnormalities (angiopathy) in the retina are
expressed in the form of thickening of the basal
membrane, microaneurism, edema of walls, and
degeneration and atrophy of the endothelium, as well as
signs of angiogenesis. Sometimes different levels of
manifestation of similar pathologic changes in this or that
of the vascular channel are noted; for instance, during
the inflammatory process an increase in the lumen and
permeability of the microvessels are more expressed in
the venous part of the vascular system of an organ (8-9).
Currently, significant attention is paid to structural
and functional changes in the cellular membranes during
studies of many pathologic states. The level of
manifestation and duration of the membrane-damaging
processes in an organism determine the clinical heaviness

cholesterol ethers) and phospholipids
(phosphatidylserine,
cardiolipin,
lysophosphatidyletanolamine, lysocardiolipin,
sphingomyelin, phosphatide acid and
lysophosphatide acid) increase. The depth of
these changes correlates with the heaviness of
the pathological process.
Key Words: alloxane diabetes, phospholipid,
vascular, hypertensive, enzymes

and peculiarities of the progress of many diseases.
Membrane destruction as a pathologic phenomenon is
predetermined, first and foremost, by the involvement of
lipids of cellular membranes in the process of peroxide
oxidation of lipids and lipolytic enzymes, which causes a
change in the lipid-protein links, and endurance of the
cellular metabolism (10-11). However, the importance of
the lipid exchange in the development of diabetic
microangiopathies is not sufficiently studied, as yet (12).
So far ample data have been amassed on the
bioeffector function of lipids and phospholipids both in an
organism on the whole, and in a separate cell.
Glycosphyngolipids have been revealed to take part in the
growth, differentiation and recognition of the cells in
intercellular interactions, as well as in the signal
transmission. They are antigens and active immune
modulators. Simpler sphingolipids and their metabolites
(sphingenin, sphingenin-1-phosphate, ceramides) as
secondary messengers take part in the process of the
growth, differentiation and apoptosis of cells. There are
numerous data on the participation of representatives of
the
phosphoinosite
cycle
(diacylglycerines,
inositolphosphate, inositol-1,4,5-triphosphate and
phosphatide acid) as secondary messengers in the process
of signalization, which stimulate some forms of protein
2+
kinase C and mobilize Ca from the intracellular depot,
etc.
A
strong
bioeffector
is
1-0-alkil-2acetylphosphatidylcholine (platelet aggregation factor),
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which regulates many biological processes in blood. At
low concentrations (1-10 mkM), lysophosphatidylcholine
stimulates the activity of protein kinase C, aggravates
cellular proliferation, stimulates the differentiation of
lymphoid cells, etc. Free fatty acids regulate the activity
of phospholipases, ion channels, ATPases, G-proteins,
protein kinases, model phosphoinositide and
sphingomyelin cycles, transfer of the hormonal
information, and transcription of genes. Oxylipins are
synthesized from polyenic fatty acids as a response to the
biological stimulus. Their effects are extremely diverse;
they participate in the regulation of most normal and
pathologic processes in an organism (13).

The lipids from the vascular wall were extracted using
the method of Keits (16). Individual lipids and
phospholipids were fractionated by horizontal
chromatography (17). The percentage of individual lipids
and phospholipids was determined by the method of
density measuring analysis.

Results and Discussion
The data obtained showed that in alloxanic diabetes
the
content
of
phosphatidylcholine,
phosphatidyletanolamine and phosphatidylinosite (with
the exception of methyl ethers of fatty acids) decreases in
the vascular wall whereas the content of all fractions of
lipids increases in the vascular wall (Table 1). The number
of these lipids significantly increases at the medium and
particularly at the heavy stage of diabetes. During the
light, medium and heavy stages the level of general
phospholipids increases by 7.7, 16.0 and 25.2%,
respectively; that of cholesterol increase by 13.7, 26.5
and 39.2%, respectively. The most pronounced increase
was that of the concentration of diglycerides,
monoglycerides, cholesterol ethers and triglycerides.
Hence, at the light stage of diabetes, an increase in the
above lipids was 1.83, 1.60, 1.54 and 1.23-fold,
respectively; at the medium stage these values were 3.0,
2.1, 2.0 and 1.53-fold; and at the heavy stage they were
4.0, 2.6, 2.73 and 1.71-fold.

The goal of our work was to study regularities in the
quantitative changes in the content of various fractions of
lipids and phospholipids in the membranes of vascular
wall cells in the normal state and under alloxanic diabetes.

Materials and Methods
Observations were made on male rats weighing 180200 g. Twelve to 16 rats were used in the experiment.
Diabetes was caused by a single intraperitoneal injection
of alloxan hydrate at a dose of 20 mg per 100 g of body
weight (14-15). They were decapitated six days post
alloxan hydrate injection. The content of glucose in the
blood was determined by the orthotoluidinic method. An
acceptable level of glucose is 76 ± 26 mg%.

Table 1.

Content of lipids in the vascular wall of rats with alloxanic diabetes (mkg/mg of tissue; number of experiments 12-16).
(Level of glucose in blood, mg %)

Lipids
Healthy rats

Diabetic rats
Light

76 ± 26

142 ± 28

General phospholipids

12.63 ± 0.42

Cholesterol

1.02 ± 0.12

Free fatty acids

1.08 ± 0.05

Medium
%

288 ± 32

13.61 ± 0.64

107.7

1.16 ± 0.13

113.7

1.21 ± 0.06

120.0

Heavy
%

428 ± 49

%

14.66 ± 0.75

116.0

15.81 ± 0.54

125.2

1.29 ± 0.13

126.5

1.42 ± 0.14

139.2

1.48 ± 0.07

137.0

1.70 ± 0.09

157.4

Methyl ethers of fatty acids

0.37 ± 0.04

0.37 ± 0.05

100.0

0.36 ± 0.04

97.3

0.36 ± 0.04

97.3

Cholesterol ethers

0.41 ± 0.06

0.63 ± 0.07

153.6

0.82 ± 0.06

200.0

1.12 ± 0.08

273.2

Monoglycerides

0.10 ± 0.02

0.16 ± 0.03

160.0

0.21 ± 0.05

210.0

0.26 ± 0.06

260.0

Diglycerides

0.06 ± 0.01

0.11 ± 0.02

183.3

0.18 ± 0.04

300.0

0.24 ± 0.05

400.0

Triglycerides

1.03 ± 0.07

1.27 ± 0.12

123.3

1.58 ± 0.16

153.4

1.76 ± 0.12

170.9

0.0807

0.0852

105.5

0.0879

108.9

0.0898

111.2

Cholesterol/phospholipid
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The 1,2-diglycerides are known to produce a
significant effect on the bilayer lipids. As model
experiments have shown (18-19), they cause damage to
bilayer organization and the appearance of an isotropic
phase in membranes, which was confirmed by nuclear
magnetic resonance (19). A decrease in the content of
monoglycerides and diglycerides causes the appearance of
heavily curved sites in the bilayer, which form folds and
intramembranic particles (18). It has long been
established that any defects in the bilayer organization of
a membrane are preferable sites the hydrolytic action of
phospholipases and proteases irrespective of the reasons
causing them (21).

Hence, if at the light stage of diabetes the level of the
above mentioned phospholipids decreased only by 3.2,
2.8 and 5.1%, at the medium stage it decreased by 10.2,
11.6 and 12.8%, and at the heavy stage by 14.7, 16.1
and
18.0%,
respectively.
A
decrease
in
phosphatidylcholine and phosphatidyletanolamine was
accompanied by a significant increase in the content of
their monoacylic forms and free fatty acids. Against the
norm at the light, medium and heavy stages of diabetes,
the level of lysophosphatidylcholines increases 1.17, 1.63
and 2.08-fold; lysophosphatidyletanolamines 1.16, 1.33
and 1.53-fold; and free fatty acids 1.20, 1.37 and 1.57fold.

Accumulation of general phospholipids in the vascular
wall of the diabetic animals took place owing to the minor
components of the phospholipid composition (Table 2),
but not to the major fractions of phospholipids. While
analyzing the quantitative content of the individual
phospholipids in the vascular wall in the diabetic animals
there was a sufficient decrease in the levels of
phosphatidylcholine, phosphatidyletanolamine and
phosphatidylinosite. The level of changes in the content of
phospholipids depended on the diabetes heaviness.
Table 2.

Conclusion
An excess accumulation of lysoforms of phospholipids
and free fatty acids in the cells of the vascular wall in
diabetes causes deep abnormalities in the structure and
the function of biological membranes (21). Samartsev
has shown that high concentrations of fatty acids block
the transport of ATP and ADP through the inner
membrane of mitochondria, inhibiting adenine nucleotide
translocase.

Content of phospholipids in the vascular wall of rats with alloxanic diabetes (mkg/mg, number of experiments 12-16).
(Level of glucose in blood, mg %)

Lipids
Healthy rats

Diabetic rats
Light

76 ± 26
Phosphatidylcholine
Phosphatidyletanolamine
Sphingomyelin
Phosphatidylserine
Phosphatidylnosite
Cardiolipin
Lysophosphati-dyletanolamine
Lysocardiolipin
Phosphatide acid
Lysophosphatide acid
Phosphatidylcholine/
phos-phatidyletanolamine
Phosphatidylcholine/
lysophosphatidylecholine
Phos-phatidyletanolamine

5.12
2.24
1.39
0.42
0.39
1.12
0.42
0.11
0.25
0.21

±
±
±
±
±
±
±
±
±
±

0.11
0.08
0.06
0.05
0.04
0.08
0.04
0.02
0.03
0.04

142 ± 28
4.96
2.20
1.59
0.56
0.37
0.37
0.49
0.13
0.39
0.42

±
±
±
±
±
±
±
±
±
±

0.19
0.09
0.06
0.06
0.03
0.03
0.04
0.02
0.04
0.05

Medium
%
96.8
98.2
114.4
133.3
94.9
130.3
116.6
118.2
156.0
200

288 ± 32
4.60
1.98
1.76
0.69
0.34
2.00
0.56
0.16
0.48
0.64

±
±
±
±
±
±
±
±
±
±

0.14
0.07
0.07
0.04
0.03
0.11
0.05
0.02
0.05
0.07

Heavy
%
89.8
88.4
126.6
164.3
87.2
178.6
133.3
145.4
192.0
304.7

428 ± 49
4.37
1.88
2.18
0.84
0.32
2.46
0.64
0.18
0.66
0.82

±
±
±
±
±
±
±
±
±
±

0.13
0.06
0.12
0.05
0.02
0.10
0.06
0.01
0.04
0.06

%
85.3
83.9
156.8
200.0
82.0
219.6
152.4
163.6
264.0
390.5

2.28

2.25

98.7

2.42

106.1

2.32

101.7

11.13
5.33

9.18
4.49

82.5
84.2

6.64
3.53

59.6
66.2

4.55
2.94

40.9
55.1
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A decrease in phosphatidylcholine, phosphatidyl
etanolamine and phosphatidylinosite and an increase in
their monoacylic form of free fatty acids in the vascular
wall in diabetes is likely to be connected with the violation
of processes of the transacylation of fatty acids into the
above mentioned phospholipids due to inhibition of the
acylase response against the activation of phospholipase
A. This results in inhibition of the synthesis of the acylic
groups of the above phospholipids.
An increase in the content of phosphatidyl serine in
the cells of the vascular wall of diabetic animals (at the
light, medium and heavy stages, 1, 1.33 and 1.64,
respectively) against a decrease in the content of
phosphatidylcholine, phosphatidyletanolamine is perhaps
a result of the enzymatic responses of methylation and
decarboxylation taking place in the cell membranes (22).
It can be assumed when there is an insulin deficit the
process of transformation of phosphatidylserine into
phosphatidyletanolamine (reaction of decarboxylation)
decelerates, which in turn causes the deceleration of the
transformation
of
phosphatidylserine
into
phosphatidylcholine (reaction of methylation).
A characteristic feature of changes in the vascular
walls in experimental diabetes is a sharp increase in the
content of cardiolipin. At the light, medium and heavy
stages of diabetes, the content of cardiolipin increases
1.30, 1.79 and 3.20-fold, respectively, in comparison
with the norm. It is known that mitochondria have a full
set of enzymes for the synthesis of cardiolipin, which are
connected with the inner membrane (21,23). In our
opinion, an increased content of cardiolipin in the vascular
wall of diabetic animals is connected with the
strengthening of the activity of diglyceride-glycero-5pphosphatidyltransferase,
phosphatidyl
glycerophosphatase and cardiolipin synthetase. An
increase in the concentration of lysocardiolipins in the
vascular wall of diabetic rats (at the light, medium and
heavy stages of the pathology 1.18, 1.45 and 1.64-fold,
respectively, of the norm) against an increase in the
amount of cardiolipin, in our opinion, is a result of an
increase in the catalytic activity of phospholipase A.
When there is a deficit of insulin in the animal
organism, the content of sphingomyelin, phosphatide acid
and lysophosphatide acid increases in the cells of the
vascular cell depending on the heaviness of the
pathological process. Hence, the level of sphingomyelin at
the light, medium and heavy stage of diabetes increases
472

1.14, 1.27 and 1.57-fold; phosphatide acid 1.56, 1.92
and 2.64-fold; and lysophosphatide acid 2.0, 3.0 and
3.9-fold of the initial value. In diabetes, an increase in
phosphatide acid, especially lysophosphatide acid, in our
opinion is connected with the increase in the catalytic
activity of phospholipase D. This enzyme is known to
carry out the hydrolysis of phospholipids and
lysophospholipids of cytoplasmic membranes and the
membranes of cell organelle with the formation of
phosphatide acid and lysophosphatide acid, as well as free
bases (23).
A decrease in the neutral phospholipids results not
only in the accumulation of lyso derivatives, but also to
the redistribution of the surface charge of the membrane
owing to a sharp growth of phosphatidylcholine,
cardiolipin and phosphatide acid, which have a negative
charge. This restructuring of the lipid content in the
membranes of the vascular wall can significantly
strengthen the adhesion of the form elements of blood
in diabetic patients. The thickening of the vascular wall in
diabetic patients is likely to be connected with the deposit
of lipid fractions in it. The other adverse factor is an
accumulation of cholesterol, which can significantly
increase the level of microviscosity of the tissue cell
membranes in the vascular wall at diabetes.
In diabetes, the ratio of cholesterol/general
phospholipids, which plays an important role in the
preservation of the membrane integrity, increases and
changes depending on the heaviness of the pathological
process.
The
ratio
of
phosphatidylcholine/phosphatidyletanolamine
under
similar conditions does not practically differ from the
norm. At the same time, the ratio of diacylic and
monoacylic forms of phospholipids, which play an
important role in the preservation of the integrity of cell
membranes and their organoids in diabetes, decreases
and correlates with the heaviness of the pathological
process. Therefore, if at the light stage of diabetes the
ratio of phosphatidylcholine/lysophosphatidylcholines and
phosphatidyletanolamine/lysophosphatidyletanolamine
decreases only 1.17 and 1.45-fold of the norm, this
implies that with the aggravation of diabetes the process
of damage in cell membranes in the vascular wall
significantly increases.
Thus, it is believed that changes in the cells of vascular
wall tissues during insulin deficit in an organism are due
to the emergence of lesions manifested in the violation of

G. M. IRGASHEVA, L. S. KLEMESHEVA, K. T. ALMATOV

lipid and phospholipid exchange, which is expressed in a
decrease
in
the
phosshatidylcholine,
phosphatidyletanolamine and phosphatidylinosite content
and in the increase in the other fractions of lipids and
phospholipids with the preservation of the concentration
of methyl fats of fatty acids. The intensity of these
changes is proportional to the heaviness of the diabetic
state.
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